Accelerator Advisory Services

It’s Never Too Soon To Translate Medical Technology Research Into a Viable Business Model. Start With Strategies Designed Specifically to Support Early-Stage Life Science Innovators.

Meaningful Reimbursement Insights

IDENTIFY & EVALUATE POTENTIAL REIMBURSEMENT PATHWAYS

One of the key factors in creating a sustainable medical technology business is the strength of your reimbursement strategy.

However, medical technology incubators and accelerator programs are well aware that the road from scientific concept to clinical solution is never a straight line. That’s why — even in the earliest stages of research and development — knowledge of reimbursement realities can make a measurable difference. With expert guidance along the way, healthcare innovators can avoid costly, time-consuming missteps.

Where can accelerator programs find vital reimbursement insight?

Look to JR Associates. Our consultants provide real-world depth and perspective needed to position emerging technologies along the challenging route from bench to bedside.

Impeccable Qualifications and Proven Results

For more than two decades, our team has been at the forefront of medical reimbursement — helping organizations from across the healthcare value chain as they navigate today’s complex, dynamic marketplace.

For more than 10 years, we’ve worked in partnership with life science accelerator programs as they shape the future with biomedical breakthroughs. For example, our founder, Judy Rosenbloom, serves as reimbursement advisor to the esteemed USC Coulter Translational Research Partnership Program. She was also a reviewer with the USC Stevens Center for Innovation “Ideas Empowered” Program, and is a guest lecturer and advisor at the USC Regulatory Science Graduate Program.

We’re ready to help you accelerate medical technology innovation

To learn more about how we add value in medtech accelerator environments, read our case brief: The Power of Reframing for Reimbursement.

Or to discuss your organization’s needs, Contact Us.